Clicky

Veracyte, Inc.(VCYT) News

Date Title
May 15 Veracyte to Participate in Upcoming Investor Conferences
May 13 Wall Street Analysts Believe Veracyte (VCYT) Could Rally 39.59%: Here's is How to Trade
May 9 Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount?
May 8 Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript
May 8 Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
May 8 Q1 2024 Veracyte Inc Earnings Call
May 8 Veracyte Inc (VCYT) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Revenue ...
May 7 Veracyte Inc (VCYT) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strong Test Performance
May 7 Veracyte Announces First Quarter 2024 Financial Results
May 6 14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding
Apr 22 Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024
Apr 22 New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
Apr 16 Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
Apr 2 What Makes Veracyte (VCYT) a Lucrative Investment?
Dec 12 Veracyte to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Dec 1 Real-World Data Presented at SUO 2023 Show that Veracyte’s Decipher Genomic Classifier Identifies Patients Whose Prostate Cancer is Likely to Progress
Nov 29 Clinical Validation Data Published in CHEST Demonstrate that Veracyte’s Percepta Nasal Swab Test Improves Lung Cancer Risk Assessment for Patients with Lung Nodules
Nov 8 Veracyte, Inc. (NASDAQ:VCYT) Q3 2023 Earnings Call Transcript
Nov 7 Veracyte Announces Third Quarter 2023 Financial Results
Nov 7 Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Availability of Its Tests for Patients Globally